Found: 7
Select item for more details and to access through your institution.
Opaganib in Coronavirus Disease 2019 Pneumonia: Results of a Randomized, Placebo-Controlled Phase 2a Trial.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 7, p. 1, doi. 10.1093/ofid/ofac232
- By:
- Publication type:
- Article
Editorial: fluticasone propionate orally disintegrating tablets—interesting concept but is it going anywhere? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 10, p. 990, doi. 10.1111/apt.15713
- By:
- Publication type:
- Article
Randomised clinical trial: the safety and tolerability of fluticasone propionate orally disintegrating tablets versus placebo for eosinophilic oesophagitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 8, p. 750, doi. 10.1111/apt.15670
- By:
- Publication type:
- Article
Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Complex (CONVERT). A Prospective, Open-Label, Randomized Study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Examining the Effect of Residual Amikacin on Sputum Culture for Nontuberculous Mycobacteria.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2017, v. 195, n. 6, p. 814, doi. 10.1164/rccm.201604-0700oc
- By:
- Publication type:
- Article
Assessing technical and biological variation in SWATH-MS-based proteomic analysis of chronic lymphocytic leukaemia cells.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-82609-2
- By:
- Publication type:
- Article